Furthermore, in a study of immunoparesis in relapsed Myeloma, Chakraborty et al. (2020) observed that the proportion of patients with full immunoparesis at first relapse was highest in IgA MM (76%), followed by IgG (60%), and then LC-MM (46%). The gene discussed is CD79A; the disease is plasma cell myeloma.